Published in Anal Biochem on April 01, 1978
Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology. J Clin Pathol (1983) 1.50
Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial. Br J Cancer (2011) 1.47
Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level. Br J Cancer (1988) 1.17
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer. Breast Cancer Res (2010) 1.12
Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br J Cancer (1992) 0.91
Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study. PLoS One (2012) 0.85
Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer (1986) 0.82
Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br Med J (Clin Res Ed) (1986) 0.81
p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group. Br J Cancer (1995) 0.80
Defining a high mortality risk group among women with primary breast cancer. Br J Cancer (1994) 0.78
Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples. Br J Cancer (1992) 0.75
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer. Breast Cancer Res Treat (2016) 0.75
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell (1983) 6.01
Mechanisms of estrogen action. Physiol Rev (2001) 5.97
Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A (1998) 5.86
Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell (1986) 4.66
Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A (1992) 4.38
Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell (1988) 3.46
Effects of hydroxyurea and 1-beta-D-arabinofuranosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur J Biochem (1971) 3.06
Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology (1997) 2.94
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab (1997) 2.73
Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J (1988) 2.66
Solution structure of the glucocorticoid receptor DNA-binding domain. Science (1990) 2.64
Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci U S A (1981) 2.63
Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev (1988) 2.47
Role of estrogen receptor beta in estrogen action. Annu Rev Physiol (2001) 2.40
Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci U S A (2000) 2.24
Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest (1999) 2.21
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21
A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A (2001) 2.12
Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol (1990) 2.12
Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci U S A (1993) 2.00
Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol (1997) 2.00
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem (2000) 2.00
Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc Natl Acad Sci U S A (1999) 1.99
Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci U S A (2000) 1.97
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest (2001) 1.95
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun (2000) 1.94
Structural insights into the mode of action of a pure antiestrogen. Structure (2001) 1.92
Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol (1995) 1.92
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A (2000) 1.90
Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol (1997) 1.90
A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol (1998) 1.82
Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature (1985) 1.80
Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res (2001) 1.77
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol (1999) 1.74
The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett (1997) 1.73
The specific DNA binding activity of the dioxin receptor is modulated by the 90 kd heat shock protein. EMBO J (1990) 1.70
Purification of the glucocorticoid receptor from rat liver cytosol. J Biol Chem (1979) 1.69
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet (1992) 1.69
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Characterization of the purified activated glucocorticoid receptor from rat liver cytosol. J Biol Chem (1984) 1.67
Ligand-dependent recruitment of the Arnt coregulator determines DNA recognition by the dioxin receptor. Mol Cell Biol (1993) 1.67
Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol Cell Biol (1989) 1.65
Identification and functional characterization of a novel mitochondrial thioredoxin system in Saccharomyces cerevisiae. J Biol Chem (1999) 1.64
Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem (1991) 1.63
Two different pathways for the maintenance of trabecular bone in adult male mice. J Bone Miner Res (2002) 1.62
Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene (2000) 1.62
Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res Treat (1999) 1.62
Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc Natl Acad Sci U S A (1986) 1.58
Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta. EMBO J (1999) 1.58
Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays (1997) 1.58
OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci U S A (1995) 1.56
Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J Biol Chem (1995) 1.56
Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55
Sex steroid induced changes in hepatic enzymes. Annu Rev Physiol (1983) 1.54
Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem Biophys Res Commun (1988) 1.53
Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO). Proc Natl Acad Sci U S A (2000) 1.51
Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county. Acta Radiol Oncol (1986) 1.51
Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial. Br J Cancer (2011) 1.47
Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation. Mol Cell Biol (1994) 1.47
The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem (1999) 1.46
Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol Cell Biol (1997) 1.46
The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol (1998) 1.45
Oestrogen receptors - an overview. J Intern Med (1999) 1.44
Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol (1995) 1.44
Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci U S A (1999) 1.44
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene (2007) 1.43
Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes Dev (1993) 1.43
Solution structure of a mammalian PCB-binding protein in complex with a PCB. Nat Struct Biol (1995) 1.40
Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain. Mol Cell Biol (2000) 1.39
Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol (2000) 1.38
Mitochondria of Saccharomyces cerevisiae contain one-conserved cysteine type peroxiredoxin with thioredoxin peroxidase activity. J Biol Chem (2000) 1.38
A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol Cell Biol (1994) 1.38
Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res (2000) 1.38
Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res (1998) 1.36
Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res (2001) 1.35
Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc Natl Acad Sci U S A (1984) 1.35
Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology (1997) 1.34
The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol (1991) 1.34
Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer (1980) 1.34
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A (1992) 1.34
Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem Biophys Res Commun (1996) 1.34
Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci U S A (2001) 1.34
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology (1985) 1.32
Requirement of hormone for thermal conversion of the glucocorticoid receptor to a DNA-binding state. Nature (1988) 1.32
Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains. Proc Natl Acad Sci U S A (1982) 1.32
Quantitative analysis of the glucocorticoid receptor-DNA interaction at the mouse mammary tumor virus glucocorticoid response element. J Biol Chem (1990) 1.32